These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 8306090)

  • 1. Cross-tolerance between delta-9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212-2 and anandamide.
    Pertwee RG; Stevenson LA; Griffin G
    Br J Pharmacol; 1993 Dec; 110(4):1483-90. PubMed ID: 8306090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of cross-tolerance between delta 9-tetrahydrocannabinol, CP 55,940 and WIN 55,212.
    Fan F; Compton DR; Ward S; Melvin L; Martin BR
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1383-90. PubMed ID: 7996450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of two endogenous fatty acid ethanolamides on mouse vasa deferentia.
    Pertwee R; Griffin G; Hanus L; Mechoulam R
    Eur J Pharmacol; 1994 Jul; 259(2):115-20. PubMed ID: 7957604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterisation of cannabinoid CB(1) receptors in the rat and mouse.
    Lay L; Angus JA; Wright CE
    Eur J Pharmacol; 2000 Mar; 391(1-2):151-61. PubMed ID: 10720647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AM630, a competitive cannabinoid receptor antagonist.
    Pertwee R; Griffin G; Fernando S; Li X; Hill A; Makriyannis A
    Life Sci; 1995; 56(23-24):1949-55. PubMed ID: 7776818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral effects of cannabinoids show differential sensitivity to cannabinoid receptor blockade and tolerance development.
    De Vry J; Jentzsch KR; Kuhl E; Eckel G
    Behav Pharmacol; 2004 Feb; 15(1):1-12. PubMed ID: 15075621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The actions of some cannabinoid receptor ligands in the rat isolated mesenteric artery.
    White R; Hiley CR
    Br J Pharmacol; 1998 Oct; 125(3):533-41. PubMed ID: 9806337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of anandamide- and fluoroanandamide-induced antinociception and cross-tolerance to delta 9-THC after intrathecal administration to mice: blockade of delta 9-THC-induced antinociception.
    Welch SP; Dunlow LD; Patrick GS; Razdan RK
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1235-44. PubMed ID: 7791096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonclassical and endogenous cannabinoids: effects on the ordering of brain membranes.
    Bloom AS; Edgemond WS; Moldvan JC
    Neurochem Res; 1997 May; 22(5):563-8. PubMed ID: 9131634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of cannabinoid receptor activity in the rat-isolated ileum myenteric plexus-longitudinal muscle preparation.
    Makwana R; Molleman A; Parsons ME
    Br J Pharmacol; 2010 Apr; 159(8):1608-22. PubMed ID: 20233228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic Δ⁹-tetrahydrocannabinol treatment in rhesus monkeys: differential tolerance and cross-tolerance among cannabinoids.
    McMahon LR
    Br J Pharmacol; 2011 Mar; 162(5):1060-73. PubMed ID: 21091643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (R)-methanandamide, but not anandamide, substitutes for delta 9-THC in a drug-discrimination procedure.
    Burkey RT; Nation JR
    Exp Clin Psychopharmacol; 1997 Aug; 5(3):195-202. PubMed ID: 9260067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of anandamide-induced tolerance: comparison to delta 9-THC-induced interactions with dynorphinergic systems.
    Welch SP
    Drug Alcohol Depend; 1997 Apr; 45(1-2):39-45. PubMed ID: 9179505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid agonists differentially substitute for the discriminative stimulus effects of Delta(9)-tetrahydrocannabinol in C57BL/6J mice.
    McMahon LR; Ginsburg BC; Lamb RJ
    Psychopharmacology (Berl); 2008 Jul; 198(4):487-95. PubMed ID: 17673980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that the plant cannabinoid Delta9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist.
    Thomas A; Stevenson LA; Wease KN; Price MR; Baillie G; Ross RA; Pertwee RG
    Br J Pharmacol; 2005 Dec; 146(7):917-26. PubMed ID: 16205722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol.
    McMahon LR
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1211-8. PubMed ID: 16943255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cannabinoid receptor activation on rabbit bisected vas deferens strips.
    Barun S; Vural IM; Dileköz E; Ercan ZS; Sarioglu Y
    Clin Exp Pharmacol Physiol; 2005 Sep; 32(9):702-7. PubMed ID: 16173925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential cholera-toxin sensitivity of supraspinal antinociception induced by the cannabinoid agonists delta9-THC, WIN 55,212-2 and anandamide in mice.
    Raffa RB; Stone DJ; Hipp SJ
    Neurosci Lett; 1999 Mar; 263(1):29-32. PubMed ID: 10218903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor-independent effects of natural cannabinoids in rat peritoneal mast cells in vitro.
    Bueb JL; Lambert DM; Tschirhart EJ
    Biochim Biophys Acta; 2001 Apr; 1538(2-3):252-9. PubMed ID: 11336796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of cannabinoid receptor ligands on electrically-evoked responses in rat isolated tracheal ring segments.
    Yousif MH; Oriowo MA
    Pharmacol Res; 1999 Nov; 40(5):415-21. PubMed ID: 10527656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.